Impact of chronic obstructive pulmonary disease on quality of life: The role of dyspnea

被引:56
作者
Ries, Andrew L.
机构
[1] Univ Calif San Diego, Ctr Med, Dept Med, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA
关键词
chronic obstructive pulmonary disease; dyspnea; health-related quality of life; pharmacologic intervention; pulmonary rehabilitation; tiotropium;
D O I
10.1016/j.amjmed.2006.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyspnea is a common symptom that accompanies a diagnosis of chronic obstructive pulmonary disease (COPD). Dyspnea often interferes with the patient's health-related quality of life (HRQOL), yet it is often underreported by the patient and underrecognized by the clinician. Reductions in objective pulmonary function measurements, such as forced expiratory volume in 1 second, are not well correlated with the patient's perception of symptoms and HRQOL. The patient's self-reported or subjective assessment is therefore important when evaluating the intensity of dyspnea and its impact on HRQOL. This article describes several well-validated questionnaires and dyspnea assessment scales that can be effective for assessing the intensity and impact that dyspnea may have on patient-perceived HRQOL. In addition, it describes the integration of pulmonary rehabilitation and specific pharmacotherapies as well as how these interventions can positively influence and modify the severity and distress of dyspnea. Effective assessment and therapeutic management of dyspnea for the patient living with COPD are opportunities to improve the patient's overall HRQOL. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:S12 / S20
页数:9
相关论文
共 45 条
  • [1] Altose MD, 2000, NEW ENGL J MED, V343, P1902
  • [2] Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
    Belman, MJ
    Botnick, WC
    Shin, JW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) : 967 - 975
  • [3] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    Bestall, JC
    Paul, EA
    Garrod, R
    Garnham, R
    Jones, PW
    Wedzicha, JA
    [J]. THORAX, 1999, 54 (07) : 581 - 586
  • [4] PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION
    BORG, GAV
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) : 377 - 381
  • [5] BURDON JGW, 1982, AM REV RESPIR DIS, V126, P825
  • [6] California Pulmonary Rehabilitation Collaborative Group, 2004, J Cardiopulm Rehabil, V24, P52
  • [7] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [8] Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD
    Casaburi, R
    Kukafka, D
    Cooper, CB
    Witek, TJ
    Kesten, S
    [J]. CHEST, 2005, 127 (03) : 809 - 817
  • [9] A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    Casaburi, R
    Mahler, DA
    Jones, PW
    Wanner, A
    San Pedro, G
    ZuWallack, RL
    Menjoge, SS
    Serby, CW
    Witek, T
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) : 217 - 224
  • [10] Pulmonary rehabilitation for COPD - A practical approach for improving ventilatory conditioning
    Celli, BR
    [J]. POSTGRADUATE MEDICINE, 1998, 103 (04) : 159 - +